Gal-32 is a Chinese hamster lung (CHL) cell mutant that is unable to grow in galactose due to a nuclearly encoded, recessive mutation affect mitochondrial (mt) protein synthesis. The goals of this proposal are to determine the molecular basis of the mutations and to clone a wild type gene that corrects the mutation. The mitochondrially synthesized subunits of NADH dehydrogenase and cytochrome c oxidase are significantly reduced in Gal-32 compared to the wild type; however, the mitochondrially synthesized subunits of ATPase are not drastically affected. In contrast to the protein levels, the mRNA and tRNA steady state levels are elevated to the mutant compared to the wild type. The differential reduction in mitochondrially encoded proteins in Gal-32 is the result of decreased translation of specific mRNAs, not increased protein degradation. In order to obtain information about the initiation, elongation, and termination steps in protein synthesis as well as the sequestering of mRNAs in particles, mitochondrial polysomes will be examined using sucrose gradient centrifugation and hybridization to complementary mtRNA probes. The size and modification of tRNAs and aminoacylation of tRNAs will be examined on one-dimensional and two-dimensional polyacrylamide gels. If differences are observed in Gal-32 compared to the wild type on one- or two- dimensional polyacrylamide gels, the 5'- and 3'-ends of tRNAs and tRNA modification will be pursued. Activity of mt translation factors, mt ribosomes, inner membrane association of mt RNAs, and polyadenylation of mt proteins will be measured. A wild type gene that corrects the Gal-32 mutation will be cloned using gene transfer. These studies will help to elucidate the regulation and factors involved in mitochondrial gene expression and may provide a model system for human patients with analogous deficiencies in the mitochondrial respiratory complexes.

Project Start
2001-01-01
Project End
2001-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
30
Fiscal Year
2001
Total Cost
$131,864
Indirect Cost
Name
Howard University
Department
Type
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Faruque, Mezbah U; Chen, Guanjie; Doumatey, Ayo P et al. (2017) Transferability of genome-wide associated loci for asthma in African Americans. J Asthma 54:1-8
Johnston, Henry Richard; Hu, Yi-Juan; Gao, Jingjing et al. (2017) Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome. Sci Rep 7:46398
Kessler, Michael D; Yerges-Armstrong, Laura; Taub, Margaret A et al. (2016) Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nat Commun 7:12521
Liu, Ching-Ti; Raghavan, Sridharan; Maruthur, Nisa et al. (2016) Trans-ethnic Meta-analysis and Functional Annotation Illuminates theĀ Genetic Architecture of Fasting Glucose and Insulin. Am J Hum Genet 99:56-75
Rand, Kristin A; Rohland, Nadin; Tandon, Arti et al. (2016) Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk. Hum Mol Genet 25:371-81
Mathias, Rasika Ann; Taub, Margaret A; Gignoux, Christopher R et al. (2016) A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nat Commun 7:12522
Ehret, Georg B (see original citation for additional authors) (2016) The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet 48:1171-1184
Kurian, P; Dunston, G; Lindesay, J (2016) How quantum entanglement in DNA synchronizes double-strand breakage by type II restriction endonucleases. J Theor Biol 391:102-12
Ogunjirin, Adebowale E; Fortunak, Joseph M; Brown, LaVerne L et al. (2015) Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen. Neurochem Res 40:2131-42
Winchester, Danyelle; Ricks-Santi, Luisel; Mason, Tshela et al. (2015) SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients. Anticancer Res 35:3811-9

Showing the most recent 10 out of 152 publications